Insider Selling: Alignment Healthcare (NASDAQ:ALHC) Insider Sells 35,951 Shares of Stock

Alignment Healthcare, Inc. (NASDAQ:ALHC) insider Hyong Kim sold 35,951 shares of Alignment Healthcare stock in a transaction dated Friday, June 12th. The shares were sold at an average price of $19.86, for a total value of $713,986.86. Following the completion of the sale, the insider owned 331,750 shares of the company’s stock, valued at $6,588,555. This trade represents a 9.78% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Hyong Kim also recently made the following trade(s):

• On Wednesday, March 18th, Hyong Kim sold 18,404 shares of Alignment Healthcare stock. The shares were sold at an average price of $17.84, for a total value of $328,327.36.

Alignment Healthcare Trading Up 0.2%

ALHC traded up $0.03 during midday trading on Monday, hitting $19.78. The company’s stock had a trading volume of 4,684,470 shares, compared to its average volume of 4,265,832. The company has a current ratio of 1.58, a quick ratio of 1.58 and a debt-to-equity ratio of 1.56. The firm has a market cap of $4.09 billion, a P/E ratio of 219.78, a PEG ratio of 2.67 and a beta of 1.14. The firm has a 50-day moving average price of $18.53 and a two-hundred day moving average price of $19.41. Alignment Healthcare, Inc. has a 52-week low of $11.63 and a 52-week high of $23.87.

Alignment Healthcare (NASDAQ:ALHC) last posted its quarterly earnings results on Thursday, April 30th. The company reported $0.05 EPS for the quarter, beating the consensus estimate of $0.01 by $0.04. The company had revenue of $1.24 billion during the quarter, compared to analysts’ expectations of $1.22 billion. Alignment Healthcare had a return on equity of 11.50% and a net margin of 0.47%.The firm’s revenue was up 33.3% on a year-over-year basis. During the same quarter in the previous year, the business earned ($0.05) EPS. On average, research analysts anticipate that Alignment Healthcare, Inc. will post 0.2 earnings per share for the current year.

Analysts Set New Price Targets

ALHC has been the topic of several analyst reports. Zacks Research raised shares of Alignment Healthcare from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, April 28th. Raymond James Financial set a $22.00 price objective on shares of Alignment Healthcare in a research report on Thursday, May 7th. UBS Group lifted their target price on Alignment Healthcare from $21.00 to $22.00 and gave the stock a “neutral” rating in a research report on Friday, May 1st. Weiss Ratings raised Alignment Healthcare from a “sell (d-)” rating to a “hold (c-)” rating in a research report on Thursday, May 7th. Finally, KeyCorp reissued an “overweight” rating on shares of Alignment Healthcare in a report on Wednesday, June 10th. One research analyst has rated the stock with a Strong Buy rating, six have given a Buy rating and three have assigned a Hold rating to the company’s stock. According to data from MarketBeat, Alignment Healthcare currently has a consensus rating of “Moderate Buy” and an average target price of $24.30.

Institutional Investors Weigh In On Alignment Healthcare

A number of institutional investors have recently made changes to their positions in the company. Bank of America Corp DE increased its holdings in shares of Alignment Healthcare by 156.5% in the 1st quarter. Bank of America Corp DE now owns 3,215,667 shares of the company’s stock valued at $56,660,000 after acquiring an additional 1,961,778 shares during the last quarter. Edgestream Partners L.P. bought a new position in Alignment Healthcare during the 1st quarter worth $4,852,000. California State Teachers Retirement System grew its stake in Alignment Healthcare by 25.4% during the 1st quarter. California State Teachers Retirement System now owns 198,200 shares of the company’s stock worth $3,492,000 after buying an additional 40,135 shares during the last quarter. Quantinno Capital Management LP grew its stake in Alignment Healthcare by 442.2% during the 1st quarter. Quantinno Capital Management LP now owns 89,387 shares of the company’s stock worth $1,575,000 after buying an additional 72,900 shares during the last quarter. Finally, Orbimed Advisors LLC bought a new position in Alignment Healthcare during the 1st quarter worth $13,937,000. 86.19% of the stock is currently owned by institutional investors.

About Alignment Healthcare

Alignment Healthcare, Inc (NASDAQ: ALHC) is a health care company specializing in value-based care for Medicare Advantage beneficiaries. The company leverages an integrated care model that combines in-home clinical services, telehealth capabilities and digital health tools to manage chronic conditions, improve outcomes and enhance patient experience.

At the core of Alignment Healthcare’s approach is a proprietary technology platform that aggregates real-time clinical and claims data to support preventive care, risk stratification and personalized care plans.